Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Non-Current Assets (2016 - 2025)

OptimizeRx's Other Non-Current Assets history spans 15 years, with the latest figure at $113.9 million for Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 31359.12% year-over-year to $113.9 million; the TTM value through Sep 2025 reached $113.9 million, up 31359.12%, while the annual FY2024 figure was $117.0 million, 9.19% down from the prior year.
  • Other Non-Current Assets for Q3 2025 was $113.9 million at OptimizeRx, down from $115.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $128.9 million in Q4 2023 and bottomed at $5051.0 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $35.7 million (2023), against an average of $51.0 million.
  • The largest annual shift saw Other Non-Current Assets plummeted 99.98% in 2022 before it surged 2551751.12% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $25.7 million in 2021, then tumbled by 99.98% to $5051.0 in 2022, then soared by 2551751.12% to $128.9 million in 2023, then dropped by 9.19% to $117.0 million in 2024, then dropped by 2.7% to $113.9 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Other Non-Current Assets are $113.9 million (Q3 2025), $115.1 million (Q2 2025), and $115.9 million (Q1 2025).